CN Patent

CN110638743B — 一种含布立西坦的组合物

Assigned to Lepu Pharmaceuticals Technology Co ltd · Expires 2023-03-28 · 3y expired

What this patent protects

本发明公开了一种含布立西坦的组合物，其含有(2S)‑2‑[(4R)‑2‑氧代‑4‑丙基四氢‑1H‑吡咯‑1‑基]丁酰胺作为活性成分，组合物中还含有一种或多种含葡萄糖单元的寡糖，该组合物中活性成分在较长期间内保持稳定。

USPTO Abstract

本发明公开了一种含布立西坦的组合物，其含有(2S)‑2‑[(4R)‑2‑氧代‑4‑丙基四氢‑1H‑吡咯‑1‑基]丁酰胺作为活性成分，组合物中还含有一种或多种含葡萄糖单元的寡糖，该组合物中活性成分在较长期间内保持稳定。

Drugs covered by this patent

Patent Metadata

Patent number
CN110638743B
Jurisdiction
CN
Classification
—
Expires
2023-03-28
Drug substance claim
No
Drug product claim
No
Assignee
Lepu Pharmaceuticals Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.